Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Automation & Control
What's New on Our Weblog
A recap of ISPE Orlando; pricing controls and political change; AstraZeneca's Tony Zook and Mylan Labs CEO interviews; performance and peer review: what do they really mean?
April 30, 2006
Add Us On Google
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
2026 AI Trends in Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Lonza CEO says the CDMO is ‘not in a capacity race’
Lonza’s Vacaville site emerges as crown jewel in CDMO’s biologics growth strategy
Samsung Biologics benefits from plant utilization, court restricts potential strike impact
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content